MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding MAIA Biotechnology, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 20 | 20 | 0 |
| Shares | 1.48M | 2.28M | +807.1K (+54.6%) |
| Value | $2.26M | $3.95M | +$1.69M (+74.8%) |
New holders (4)
Institutions that held MAIA Biotechnology, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 28,783 | $51.8K | 0.00% |
| Marshall Wace, LLP | 16,165 | $29.1K | 0.00% |
| Centerpoint Advisory Group | 15,730 | $28.3K | 0.02% |
| Raymond James Financial Inc | 100 | $180 | 0.00% |
Sold out (4)
Institutions that held MAIA Biotechnology, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Halter Ferguson Financial Inc. | 237,356 | $363.2K |
| Susquehanna International Group, LLP | 55,100 | $84.3K |
| Naviter Wealth, LLC | 10,000 | $16.2K |
| Bernard Wealth Management Corp. | 500 | $765 |